Kevin S. Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kevin S. Oh has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Jay S. Loeffler
Department of Radiation Oncology Massachusetts General Hospital Boston Massachusetts
2 shared publications- Arjun Sahgal
Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
1 shared publication Ayal A. Aizer
Harvard Radiation Oncology Program, Boston, Massachusetts
1 shared publication- Brian Winey
Massachusetts General Hospital and Harvard Medical School
1 shared publication Daniel A. Hamstra
1 shared publication- Daniel K. Fahim
Department of Neurosurgery, Oakland University William Beaumont School of Medicine, Rochester, MI 48309, USA
1 shared publication
Latest Publications
- Open Access
Underutilization of radiation therapy in patients with glioblastoma
BACKGROUND: Randomized trials have demonstrated that radiation improves survival in patients with glioblastoma. The purpose of this study was to characterize the risk factors and impact of omission of radiation therapy in such patients.METHODS: The Surveillance, Epidemiology, and End Results (SEER) program was used to identify 22,777 patients diagnosed with glioblastoma between 1988 and 2007. Multivariable logistic regression was employed to identify predictors associated with omission of radiation. Cox regression was used to characterize the impact of omitting radiation on all‐cause mortality.RESULTS: Among the entire cohort, 16,863 of 22,777 patients (74%) received radiation, whereas 5914 of 22,777 patients (26%) did not. Factors associated with omission of radiation included older age (OR = 1.048 per year increase, 95% CI = 1.046‐1.051, P < .001), lower annual income (OR = 0.93 per $10,000 increase, 95% CI = 0.90‐0.96, P < .001), African American race (reference = white, OR = 1.19, 95% CI = 1.03‐1.37, P = .02), Hispanic race (OR = 1.34, 95% CI = 1.19‐1.50, P < .001), Asian American race (OR = 1.24, 95% CI = 1.04‐1.48, P < .001), unmarried status (OR = 1.71, 95% CI = 1.60‐1.83, P < .001), and subtotal resection/biopsy (OR = 1.82, 95% CI = 1.69‐1.96, P < .001). The use of radiation was significantly associated with improved overall survival (2‐year survival: 14.6% versus 4.2%, P < .001; adjusted HR = 2.09, 95% CI = 2.02‐2.16, P < .001). When the population was restricted to patients < 50 years old, these findings remained largely unchanged.CONCLUSIONS: Radiation therapy is associated with survival benefit in patients with glioblastoma, and sociodemographic factors play a significant role in the underutilization of radiation. The underlying causes for these disparities in care require further research. Cancer 2014;120:238–243. © 2013 American Cancer Society.
Open AccessUnderutilization of radiation therapy in patients with glioblastoma
BACKGROUND: Randomized trials have demonstrated that radiation improves survival in patients with glioblastoma. The purpose of this study was to characterize the risk factors and impact of omission of radiation therapy in such patients.METHODS: The Surveillance, Epidemiology, and End Results (SEER) program was used to identify 22,777 patients diagnosed with glioblastoma between 1988 and 2007. Multivariable logistic regression was employed to identify predictors associated with omission of radiation. Cox regression was used to characterize the impact of omitting radiation on all‐cause mortality.RESULTS: Among the entire cohort, 16,863 of 22,777 patients (74%) received radiation, whereas 5914 of 22,777 patients (26%) did not. Factors associated with omission of radiation included older age (OR = 1.048 per year increase, 95% CI = 1.046‐1.051, P < .001), lower annual income (OR = 0.93 per $10,000 increase, 95% CI = 0.90‐0.96, P < .001), African American race (reference = white, OR = 1.19, 95% CI = 1.03‐1.37, P = .02), Hispanic race (OR = 1.34, 95% CI = 1.19‐1.50, P < .001), Asian American race (OR = 1.24, 95% CI = 1.04‐1.48, P < .001), unmarried status (OR = 1.71, 95% CI = 1.60‐1.83, P < .001), and subtotal resection/biopsy (OR = 1.82, 95% CI = 1.69‐1.96, P < .001). The use of radiation was significantly associated with improved overall survival (2‐year survival: 14.6% versus 4.2%, P < .001; adjusted HR = 2.09, 95% CI = 2.02‐2.16, P < .001). When the population was restricted to patients < 50 years old, these findings remained largely unchanged.CONCLUSIONS: Radiation therapy is associated with survival benefit in patients with glioblastoma, and sociodemographic factors play a significant role in the underutilization of radiation. The underlying causes for these disparities in care require further research. Cancer 2014;120:238–243. © 2013 American Cancer Society.
- 12 September 2013
- Published by Harborside Press, LLC in Journal of the National Comprehensive Cancer Network
- Vol. 11 (9) , 1153-1164
Clinical Discussion and Review of the Management of Brain Metastases
Brain metastases are common in patients with cancer and are associated with a poor prognosis. Optimal treatment requires an integrative multidisciplinary approach, and therapeutic options may include stereotactic radiosurgery, whole-brain radiation therapy, surgical resection, chemotherapy, and targeted agents. The goals of therapy are to prolong survival, preserve neurologic function, and palliate symptoms. This article outlines the various therapeutic modalities, factors that guide treatment decisions, and medical management of frequently encountered complications of brain metastases. Brain metastases are common in patients with cancer and are associated with a poor prognosis. Optimal treatment requires an integrative multidisciplinary approach, and therapeutic options may include stereotactic radiosurgery, whole-brain radiation therapy, surgical resection, chemotherapy, and targeted agents. The goals of therapy are to prolong survival, preserve neurologic function, and palliate symptoms. This article outlines the various therapeutic modalities, factors that guide treatment decisions, and medical management of frequently encountered complications of brain metastases.
- 12 September 2013
- Published by Harborside Press, LLC in Journal of the National Comprehensive Cancer Network
- Vol. 11 (9) , 1153-1164
Clinical Discussion and Review of the Management of Brain Metastases
Brain metastases are common in patients with cancer and are associated with a poor prognosis. Optimal treatment requires an integrative multidisciplinary approach, and therapeutic options may include stereotactic radiosurgery, whole-brain radiation therapy, surgical resection, chemotherapy, and targeted agents. The goals of therapy are to prolong survival, preserve neurologic function, and palliate symptoms. This article outlines the various therapeutic modalities, factors that guide treatment decisions, and medical management of frequently encountered complications of brain metastases. Brain metastases are common in patients with cancer and are associated with a poor prognosis. Optimal treatment requires an integrative multidisciplinary approach, and therapeutic options may include stereotactic radiosurgery, whole-brain radiation therapy, surgical resection, chemotherapy, and targeted agents. The goals of therapy are to prolong survival, preserve neurologic function, and palliate symptoms. This article outlines the various therapeutic modalities, factors that guide treatment decisions, and medical management of frequently encountered complications of brain metastases.
- Open Access
- 27 June 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 158
A multi-national report on methods for institutional credentialing for spine radiosurgery
Stereotactic body radiotherapy and radiosurgery are rapidly emerging treatment options for both malignant and benign spine tumors. Proper institutional credentialing by physicians and medical physicists as well as other personnel is important for the safe and effective adoption of spine radiosurgery. This article describes the methods for institutional credentialing for spine radiosurgery at seven highly experienced international institutions.
- 27 June 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 158
Open AccessA multi-national report on methods for institutional credentialing for spine radiosurgery
Stereotactic body radiotherapy and radiosurgery are rapidly emerging treatment options for both malignant and benign spine tumors. Proper institutional credentialing by physicians and medical physicists as well as other personnel is important for the safe and effective adoption of spine radiosurgery. This article describes the methods for institutional credentialing for spine radiosurgery at seven highly experienced international institutions.
- 1 November 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (4) , e481-e488
Outcomes of Multidisciplinary Management in Pediatric Low-Grade Gliomas
- 1 November 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (4) , e481-e488
Outcomes of Multidisciplinary Management in Pediatric Low-Grade Gliomas
- 5 July 2011
- Published by Springer Nature
- p. 151-166
Radiation Therapy in the Management of Cushing’s Disease
- 5 July 2011
- Published by Springer Nature
- p. 151-166
Radiation Therapy in the Management of Cushing’s Disease